BioCryst Pharmaceuticals Inc (BCRX) support and resistance · rev $374.7M
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
This page maps BioCryst Pharmaceuticals Inc (BCRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
BCRX currently screens at market cap $1.83B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BCRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BCRX quote page for the session range and the stock page for the full model.
Not investment advice.